Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.
复制标题
DOI:
10.1038/nature11557
复制
发表时间:
2012-11-22
期刊:
影响因子:
64.8
通讯作者:
Izpisua Belmonte, Juan Carlos
中科院分区:
文献类型:
--
作者:
Liu, Guang-Hui;Qu, Jing;Suzuki, Keiichiro;Nivet, Emmanuel;Li, Mo;Montserrat, Nuria;Yi, Fei;Xu, Xiuling;Ruiz, Sergio;Zhang, Weiqi;Wagner, Ulrich;Kim, Audrey;Ren, Bing;Li, Ying;Goebl, April;Kim, Jessica;Soligalla, Rupa Devi;Dubova, Ilir;Thompson, James;Yates, John, III;Esteban, Concepcion Rodriguez;Sancho-Martinez, Ignacio;Izpisua Belmonte, Juan Carlos
Nuclear architecture defects have been shown to correlate with the manifestation of a number of human diseases as well as aging. It is then plausible that diseases whose manifestations correlate with aging might be connected to the appearance of nuclear aberrations over time. We decided to evaluate nuclear organization in the context of aging-associated disorders by focusing on a Leucine Rich Repeat Kinase 2 (LRRK2) dominant mutation (G2019S) shown to associate with familial and sporadic Parkinson’s Disease (PD), as well as impairment of adult neurogenesis in mice. Here, we report on the generation of PD patient-derived induced pluripotent stem cells (iPSCs) and the implications of LRRK2(G2019S) in human neural stem cell (NSC) populations. Mutant NSCs showed increased susceptibility to proteasomal stress as well as passage-dependent deficiencies in clonal expansion and neuronal differentiation. Disease phenotypes were rescued by targeted correction of the LRRK2(G2019S) mutation with its wild-type counterpart in PD-iPSCs and recapitulated upon targeted knock-in of LRRK2(G2019S) in human embryonic stem cells (hESCs). Analysis of human brain tissue showed nuclear envelope impairment in clinically diagnosed Parkinson’s patients. Altogether, our results identify the nucleus as a previously unknown cellular organelle in Parkinson’s pathology and may help open new avenues for PD diagnoses as well as potential development of therapeutics targeting this fundamental cell structure.
登录
查看更多内容
影响因子:
3.5
作者:
Kanao, Tomoko;Venderova, Katerina;Imai, Yuzuru
通讯作者:
Imai, Yuzuru
影响因子:
23.9
作者:
Liu, Guang-Hui;Suzuki, Keiichiro;Qu, Jing;Sancho-Martinez, Ignacio;Yi, Fei;Li, Mo;Kumar, Sachin;Nivet, Emmanuel;Kim, Jessica;Soligalla, Rupa Devi;Dubova, Ilir;Goebl, April;Plongthongkum, Nongluk;Fung, Ho-Lim;Zhang, Kun;Loring, Jeanne F.;Laurent, Louise C.;Izpisua Belmonte, Juan Carlos
通讯作者:
Izpisua Belmonte, Juan Carlos
DOI:
10.1073/pnas.0806976105
发表时间:
2008-09-16
影响因子:
11.1
作者:
Suzuki, Keiichiro;Mitsui, Kaoru;Mitani, Kohnosuke
通讯作者:
Mitani, Kohnosuke
影响因子:
9.9
作者:
Thaler, Avner;Mirelman, Anat;Giladi, Nir
通讯作者:
Giladi, Nir
影响因子:
64.8
作者:
Liu, Guang-Hui;Barkho, Basam Z.;Ruiz, Sergio;Diep, Dinh;Qu, Jing;Yang, Sheng-Lian;Panopoulos, Athanasia D.;Suzuki, Keiichiro;Kurian, Leo;Walsh, Christopher;Thompson, James;Boue, Stephanie;Fung, Ho Lim;Sancho-Martinez, Ignacio;Zhang, Kun;Yates, John, III;Izpisua Belmonte, Juan Carlos
通讯作者:
Izpisua Belmonte, Juan Carlos